Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 開頭術 | から $28,500 | から $5,650 | から $20,000 |
| 脳腫瘍摘出術 | から $38,500 | から $19,710 | から $60,000 |
| 下垂体腫瘍摘出術 | から $28,000 | から $13,500 | から $30,000 |
| ガンマナイフ | から $13,800 | から $6,300 | から $32,000 |
| 経鼻的腫瘍切除術 | - | から $8,000 | から $30,000 |
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
この医師は、著名な神経外科医であり、現在、European Association of Neurosurgical Societies (EANS) の会長を務めています。テルアビブ大学のサックラー医学部を卒業し、チャイム・シェバ医療センターでのローテーションインターンシップを修了し、アメリカのAmerican Association of Neurosurgeryと協力しました。動脈瘤、脳血管病変、脳腫瘍、最小侵襲の脳および脊椎手術などの疾患を専門とし、脳マッピングや深部脳刺激 (DBS) にも精通しています。神経学への貢献により、ボレンスタイン賞とゴールドヒルシュ財団賞を受賞しています。
Sourasky Medical Center, Hadassah Medical Center, and Assuta Medical Center are Israel's premier facilities for pituitary adenoma treatment. These JCI-accredited institutions specialize in endoscopic transnasal resection. This minimally invasive approach allows surgeons to remove tumors through the nasal cavity without external incisions.
Bookimed Expert Insight: Sourasky Medical Center stands out because it integrates massive patient volumes with research-led care. They serve over 1.8 million patients yearly and perform 34,000 surgeries. This high frequency allows specialists like Dr. Zvi Ram to maintain expertise in complex, recurrent adenomas. Patients benefit from this concentrated experience, as surgeons manage more rare cases than smaller regional centers.
Patient Consensus: Patients note that Israeli centers often suggest aggressive minimally invasive surgery when other countries recommend waiting. Successful outcomes include hormone levels normalizing within months and significantly shorter recovery times.
A pituitary adenoma is not cancerous. These tumors are almost always benign and originate in glandular tissue. They grow slowly and do not spread to distant organs. Malignant cases, called pituitary carcinomas, represent less than 0.1% of all diagnosed pituitary growths.
Bookimed Expert Insight: Clinical data from major Israeli centers shows a strong trend toward minimally invasive techniques. Prof. Margalit Navo at Sourasky Medical Center has performed over 100 successful skull base surgeries. Similarly, Dr. Samuel Moskovichi at Hadassah Medical Center focuses on transnasal endoscopic access. This approach allows surgeons to remove benign tumors through the nose without external incisions. This significantly reduces recovery time compared to traditional craniotomy.
Patient Consensus: Many patients initially confuse the word tumor with cancer, but doctors quickly clarify that adenomas are benign. Those treated in Israel emphasize that even large 3cm tumors are usually non-cancerous and manageable with medication like cabergoline.
Primary treatment for pituitary adenoma in Israel focuses on minimally invasive transnasal resection and specialized medical management. Surgeons at JCI-accredited centers like Sourasky Medical Center achieve a 90% success rate by removing tumors through the nasal cavity. This approach eliminates external scarring and shortens hospital stays to 3 days.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical specialization, with experts like Dr. Margalit Navo performing over 100 skull base procedures. Data shows that private facilities like Assuta Medical Center handle 92,000 operations annually, allowing patients to select specific senior surgeons. This choice is vital because outcomes improve significantly when a neurosurgeon performs more than 50 adenoma resections per year.
Patient Consensus: Patients note that recovery from endoscopic surgery is remarkably fast, often returning home within 72 hours. Many emphasize the importance of choosing English-fluent multidisciplinary teams to coordinate between neurosurgery and endocrinology specialists effectively.